CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.

by Young Wha Koh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh
Published 2014-01-01

GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression

by Young Wha Koh, Jae-Ho Han, Seong Yong Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh
Published 2017-03-01

Breast implant–associated anaplastic large cell lymphoma: the first South Korean case

by Jongwon Lee, Hyungwoo Cho, Dok Hyun Yoon, Eun Key Kim, Gyungyub Gong, Cheolwon Suh, Joo-ryung Huh
Published 2020-09-01

Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution

by Meejeong Kim, Hee Sang Hwang, Hyungwoo Cho, Dok Hyun Yoon, Cheolwon Suh, Chan Sik Park, Heounjeong Go, Jooryung Huh
Published 2021-09-01

Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients

by Gil-Sun Hong, Eun Jin Chae, Jin-Sook Ryu, Sun Young Chae, Hyo Sang Lee, Dok Hyun Yoon, Cheolwon Suh
Published 2021-01-01

Angiosarcoma of the Retroperitoneum: Report on a Patient Treated with Sunitinib

by Changhoon Yoo, Jeong-Eun Kim, Shin-Kyo Yoon, Song Cheol Kim, Jin-Hee Ahn, Tae Won Kim, Cheolwon Suh, Jae-Lyun Lee
Published 2009-01-01

First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

by Ho-Young Yhim, Dok Hyun Yoon, Seok Jin Kim, Deok-Hwan Yang, Hyeon-Seok Eom, Kyoung Ha Kim, Yong Park, Jin Seok Kim, Hyo Jung Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak
Published 2020-08-01

Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma

by Jwa Hoon Kim, Hyungwoo Cho, Heungsup Sung, Ah Ra Jung, Yoon Sei Lee, Sang-wook Lee, Jin-Sook Ryu, Eun Jin Chae, Kyoung Won Kim, Jooryung Huh, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh
Published 2021-02-01

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

by Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jung Yong Hong, Ho Sup Lee, Sung Yong Oh, Ho-Jin Shin, Jee Hyun Kong, Jun Ho Yi, Kana Sakamoto, Young Hyeh Ko, Jooryung Huh, Seung-Sook Lee, Kengo Takeuchi, Dong-Yeop Shin, Cheolwon Suh, Won Seog Kim
Published 2019-11-01

Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study

by Ki-Seong Eom, Seok Jin Kim, Je-Jung Lee, Cheolwon Suh, Jin Seok Kim, Sung-Soo Yoon, Byung Soo Kim, Hye Jin Kang, Young Jin Choi, Chul Soo Kim, Yang Soo Kim, Jae-Yong Kwak, Yoo Jin Kim, Young Don Joo, Yeung-Chul Mun, Deog Yeon Jo, Joon Seong Park, Chi-Young Park, Sung-Hyun Kim, Chang-Ki Min
Published 2014-01-01

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

by Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong-Won Lee, Jae Hoon Lee, Ho Sup Lee, Ho-Jin Shin, Cheolwon Suh
Published 2019-10-01

Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis

by Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yong Oh, Hun Mo Ryoo, Hyo Jung Kim, Won Seog Kim
Published 2021-03-01